The microcirculation in atherogenesis

Cardiovascular Research

Volumn 32, Issue 4, 1996, Pages 781-788

  Lehr, Hans Anton ^a,c   Messmer, Konrad ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Atherosclerosis; Diabetes; Hypercholesterolemia; Hypertension; Microcirculation

Indexed keywords

ARTERIOSCLEROSIS; ATHEROGENESIS; ATHEROSCLEROSIS; HAMSTER; HUMAN; LEUKOCYTE ADHERENCE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ARTERIOSCLEROSIS; CELL COMMUNICATION; HUMANS; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0030270878     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(96)00164-2     Document Type: Review

References (61)

1. [1] Virchow R. Über die akute Entzündung der Arterien. Virchows Arch Path Anat 1857;1:272-378.
2. [2] Ross R, and Glomset JA. The pathogenesis of atherosclerosis. N Engl J Med 1976;295:420-425.
3. [3] Ross R. Atherosclerosis: a defense mechanism gone awry. Am J Pathol 1993;143:987-1002.
4. [4] Kvernebo K, Slasgvold CE, Stranden E. Laser Doppler flowmetry in evaluation of skin post-ischaemic reactive hyperaemia. A study in healthy volunteers and atherosclerotic patients. J Cardiovasc Surg Torino 1989;30:70-75.
5. [5] Tur E, Politi Y, Rubinstein A. Cutaneous blood flow abnormalities in hypertriglyceridemia. J Invest Dermatol 1994;103:597-600.
6. [6] Yamamoto H, Bossaller C, Cartwright Jr J, Henry PD. Videomicroscopic demonstration of defective cholinergic arteriolar vasodilation in atherosclerotic rabbit. J Clin Invest 1988;81:1752-1758.
7. [7] Sellke FW, Armstrong ML, Harrison DG. Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circulation 1990;81:1586-1593.
8. [8] Chilian WM, Dellsperger KC, Layne SM, et al. Effects of atherosclerosis on the coronary microcirculation. Am J Physiol 1990;258:H529-H539.
9. [9] Kyrle PA, Minar E, Brenner B, et al. Thromboxane A2 and prostacyclin generation in the microvasculature of patients with atherosclerosis - effect of low-dose aspirin. Thromb Haemost 1989;61:374-377.
10. [10] Kuo L, Davis MJ, Cannon MS, Chilian WM, Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation. Circ Res 1992;70:465-476.
11. [11] Zeiher AM, Krause T, Schachinger V, Minners J, Moser E. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation 1995;91:2345-2352.
12. [12] Harrison DG, Ohara Y. Physiologic consequences of increased vascular stresses in hypercholesterolemia and atherosclerosis: implications for impaired vasomotion. Am J Cardiol 1995;75:75B-81B.
13. [13] Heistad DD, Armstrong ML, Marcus ML, Piegors DJ, Mark AL. Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circ Res 1984;54:711-718.
14. [14] Shimokawa H, Vanhoutte PM. Dietary cod liver oil improves endothelium-dependent responses in hypercholesterolemic and atherosclerotic porcine coronary arteries. Circulation 1984;78:1421-1430.
15. [15] Gilligan DM, Guetta V, Panza JA, Quyyumi AA, Cannon RO. Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation 1994;90:35-41.
16. [16] Kuguyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 1990;344:160-162.
17. [17] Xiu RJ, Freyschuss A, Xing X, Berglund L, Henriksson P, Björkhem J. The antioxidant butylated hydroxytoluene prevents early cholesterol-induced microcirculatory changes in rabbits. J Clin Invest 1995;93:2732-2737.
18. [18] Bieber CP, Hunt SA, Schwinn DA. Complications in long-term survivors of cardiac transplantation. Transplant Proc 1981;13:207-211.
19. [19] Oguma S, Belle S, Starzl TE, Demetris AJ. A histometric analysis of chronically rejected human liver allografts. Insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors. Hepatology 1989;9:204-209.
20. [20] Rossmann P, Jirka J, Chadimova M, Reneltova I, Saudek F. Arteriolosclerosis of the human renal allograft: morphology, origin, life history and relationship to cyclosporin therapy. Virchows Arch A Pathol Anat Histopathol 1991;418:129-141.
21. [21] Winters GL. The pathology of heart allograft rejection. Arch Pathol Lab Med 1991;115:266-272.
22. [22] Libby P, Salomon RN, Payne DD, Schoen FJ, Pober JS. Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis. Transplant Proc 1989;21:3677-3684.
23. [23] Foster M, Wenham PW, Rowe PA, et al. The late results of renal transplantation and the importance of chronic rejection as a cause of graft loss. Ann R Coll Surg Engl 1989;71:44-47.
24. [24] Mcdonald K, Rector TS, Braulin EA, Kubo SH, Olivari MT. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Pathol 1989;64:359-362.
25. [25] Fellstroem BC, Larsson E. Pathogenesis and treatment perspectives of chronic graft rejection (Cvr). Immunol Rev 1993;134:83-98.
26. [26] Land W, Schneeberger H, Schleibner S. et al. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 1994;57:211-217.
27. [27] Häyry P, Yilmaz S. Chronic allograft rejection: an update. Transplant Proc 1994;26:3159-3160.
28. [28] Granger DN, Benoit JN, Suzuki M, Grisham MB, Leukocyte adherence to venular endothelium during ischemia-reperfusion. Am J Physiol 1989;257:G683-G688.
29. [29] Lehr HA, Guhlmann A, Nolte D, Keppler D, Messmer K. Leukotrienes as mediators in postischemic leukocyte/endothelium interaction in a microcirculation model in the hamster. J Clin Invest 1991;87:2036-2041.
30. [30] Wanders A, Akyürek ML, Waltenberger J et al. Ischemia-induced transplant arteriosclerosis in the rat. Arterioscler Thromb Vasc Biol 1995;15:145-155.
31. [31] Tillius SG, Heemann U, Hancock WW, Azuma H, Tilney NL. Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection. Ann Surg 1994;220:425-435.
32. [32] Gaudin PB, Rayburn BK, Hutchins GM, et al. Peritransplant injury to the myocardium associated with the development of accelerated arteriosclerosis in heart transplant recipients. Am J Surg Pathol 1994;18:338-346.
33. [33] Wolinsky H, Glagov S. Nature and species differences in the medial distribution of aortic vaso vasorum in mammals. Circ Res 1967;20:409-421.
34. [34] Barger AC, Beewkes RM, Lecompte PM. Vaso vasorum and neovascularization of human coronary arteries: a possible role in the pathophysiology of atherosclerosis, N Engl J Med 1984;310:175-177.
35. [35] Barger AC, Beewkes R. Rupture of coronary vaso vasorum as a trigger of acute myocardial infarction. Am J Cardiol 1990;66:41G-43G.
36. [36] Whereat AF. Oxygen consumption of normal and atherosclerotic intima. Circ Res 1961;9:6571-6575.
37. [37] Alpern-Elran H, Morog N, Robert F, Hoover F, Kalant N, Brem S. Angiogenic activity of the atherosclerotic carotid artery plaque. J Neurosurg 1989;70:942-945.
38. [38] Brogi E, Winkles J, Libby P. Regional expression of acidic and basic fibroblast growth factor in human atheroma and non-atherosclerotic arteries. Circulation 1990;86:I85.
39. [39] Nikol S, Issner JM, Pickering JG, Kearney M, Leclerc G, Weir L. Expression of transforming growth factor beta 1 is increased in human vascular restenosis lesions. J Clin Invest 1992;90:1582-1592.
40. [40] Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS. Detection, localization of tumor necrosis factor in atheroma. Am J Cardiol 1990;65:297-302.
41. [41] Zhang Y, Cliff WJ, Schoefl GI, Higgins G. Immunohistochemical study of intimai microvessels in coronary atherosclerosis. Am J Pathol 1993;143:164-172.
42. [42] Alderson LM, Endemann G, Lindsey S, Pronczuk A, Hoover RL, Haves KC. LDL enhances monocyte adhesion to endothelial cells in vitro. Am J Pathol 1986;123:334-342.
43. [43] Pritchard Jr KA, Schwarz SM, Medow MS, Stemerman MB. Effect of low-density lipoprotein on endothelial cell membrane fluidity and mononuclear cell attachment. Am J Physiol 1991;260:C43-C49.
44. [44] Frostegard J, Nilsson J, Haegerstrand A, Hamsten A, Wigzell H. Gidlund M. Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc Natl Acad Sci USA 1990;87:904-908.
45. [45] Turner SR, Campbell JA, Lynn WS. Polymorphonuclear leukocyte chemotaxis toward oxidized lipid components of cell membranes. J Exp Med 1975;141:1437-1441.
46. [46] Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA 1987;84:2995-2998.
47. [47] Liao F, Berliner JA, Mehrabian M, et al. Minimally modified low density lipoprotein is biologically active in vivo in mice. J Clin Invest 1991;87:2253-2257.
48. [48] Berliner JA, Territo MC, Sevanian A, et al. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 1990;85:1260-1266.
49. [49] Lehr HA, HÜBner C, Nolte D, et al. Oxidatively modified low density lipoprotein stimulates leukocyte adherence to microvascular endothelium in vivo. Res Exp Med 1991;191:85-90.
50. [50] Lehr HA, Hübner C, Finckh B, et al. Role of leukotrienes in leukocyte adhesion following systemic administration of oxidatively modified human low density lipoprotein in hamsters. J Clin Invest 1991;88:9-14.
51. [51] Liao L, Granger DN. Modulation of oxidized low-density lipoprotein-induced microvascular dysfunction by nitric oxide. Am J Physiol 1995;268:H1643-H1650.
52. [52] Lehr HA, Olofsson AM, Carew TE, et al. P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo. Lab Invest 1994;71:380-386.
53. [53] Lehr HA, Frei B, Olofsson AM, Carew TE, Arfors KE. Protection from oxidized LDL-induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C, but not by vitamin E. Circulation 1995;91;1525-1532.
54. [54] Lehr HA, Becker M, Seemüller J, et al. Microvascular events during the development of atherosclerosis: mediator cross-talk in oxidized LDL-induced leukocyte/endothelium interaction. Prog Appl Microcirc 1995;21:79-89.
55. [55] Lehr HA, Hübner C, Nolte D, Kohlschütter A, Messmer K. Dietary fish oil reduces leukocyte/endothelium interaction following systemic administration of oxidatively modified low density lipoprotein. Circulation 1991;84:1725-1731.
56. [56] Lehr HA, Becker MS, Marklund L, et al. Superoxide-dependent stimulation of leukocyte adhesion by oxidatively modified LDL in vivo. Arterioscler Thromb 1992;12:824-829.
57. [57] Lehr HA, Seemüller J, Hübner C, Menger MD, Messmer K. Oxidized LDL-induced leukocyte/endothelium interaction in vivo involves the receptor for platelet activating factor. Arterioscler Thromb 1993;13:1013-1018.
58. [58] Smiley PL, Stremler KE, Prescott SM, Zimmerman GA, McIntyre TM. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor. J Biol Chem 1991;266:11104-11110.
59. [59] Lehr HA, Kröber M, Vajkoczy P. et al. Stimulation of leukocyte/endothelium interaction by oxidized low-density lipoprotein in hairless mice: involvement of Cd11b/Cd18 adhesion receptor complex. Lab Invest 1993;68:388-3394.
60. [60] Lehr HA, Krombach F, MÜNzing S. et al. In vitro effects of oxidized low density lipoprotein on Cd11b/Cd18 and L-selectin presentation on neutrophils and monocytes with relevance for the in vivo situation. Am J Pathol 1995;146:218-227.
61. [61] Nagelkerke JF, Bakkeren HF, Kuipers F, Vonk RJ, van Berkel TJC. Hepatic processing of the cholesteryl ester from low density lipoprotein in the rat. J Biol Chem 1986;261:8908-8913.